Results for the quarter and year ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mysore Petro Chemicals reported FY25 revenue from operations of Rs. 3,347.85 lakhs, up about 30% from Rs. 2,579.86 lakhs in FY24 (standalone). However, the company swung to a standalone net loss of Rs. 766.47 lakhs versus a profit of Rs. 916.29 lakhs last year, driven by large exceptional items totalling Rs. 1,332.59 lakhs. These included a Rs. 2,534.59 lakh impairment/fair value loss on its UK subsidiary Q C Polymer Ltd (which entered voluntary liquidation in December 2024), a Rs. 1,180.11 lakh loss on deconsolidation of that subsidiary, partly offset by a Rs. 1,403.75 lakh gain on sale of immovable property. Consolidated PAT fell to Rs. 304.34 lakhs from Rs. 747.12 lakhs. Operating cash flow remained negative at Rs. (314.44) lakhs standalone. The Board recommended a 20% dividend (Rs. 2 per share). The auditor issued an unmodified opinion with an Emphasis of Matter flagging the subsidiary loss.
The headline loss is driven mainly by one-time write-offs on a failed overseas subsidiary rather than weak core operations, which may limit the downside; however, standalone EBITDA margin has compressed sharply (from ~46% to ~22% on revenue) and dividend continuity signals management confidence. Shareholders should watch recovery from the subsidiary insurance and legal claims noted in the filing.